Navigation Links
Neurologix Announces First Quarter 2011 Financial Results
Date:5/13/2011

ization of $394 and $364 at March  31, 2011 and December 31, 2010, respectively

1,110

1,065Other assets

5

5Total assets

$7,067

$9,677LIABILITIES AND STOCKHOLDERS' DEFICITCurrent liabilities:Accounts payable and accrued expenses

$2,321

$2,302Notes payable, net of discount

5,387

4,695Total current liabilities

7,708

6,997Derivative financial instruments, at estimated fair value - warrants

5,497

6,840Total liabilities

13,205

13,837Commitments and contingenciesStockholders' deficit: Preferred stock; 5,000,000 shares authorizedSeries A – Convertible, $0.10 par value; 650 shares designated, 645 shares issued and outstanding at March  31, 2011 and December 31, 2010, with an aggregate liquidation preference of $1

-

-Series C – Convertible, $0.10 par value; 700,000 shares designated, 278,849 shares issued and outstanding  at March  31, 2011 and December 31, 2010 with an aggregate liquidation preference of $8,086 and $8,369 at March  31, 2011 and December 31, 2010, respectively

28

28Series D – Convertible, $0.10 par value; 792,100 shares designated, 734,898 shares issued and outstanding at March  31, 2011 and December 31, 2010, with an aggregate liquidation preference of $32,017 and $32,547 at March  31, 2011 and December 31, 2010, respectively

73

73 Common Stock:$0.001 par value; 100,000,000 shares authorized, 27,918,148 shares issued and outstanding at March 31, 2011 and December 31, 2010

28

28 Additional paid-in capital

57,578

57,474Deficit accumulated during the development stage

(63,845)

(61,763)Total stockholders' deficit

(6,138)

(4,160)Total liabilities and stockholders' deficit

$7,067

$9,677NEUROLOGIX, INC.(A Development Stage Company)STATEMENTS OF OPERATIONS(UNAUDITED)(Amo
'/>"/>

SOURCE Neurologix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. New Details Presented at the World Parkinson Congress on Neurologixs Successful Phase 2 Trial of Gene Therapy for Parkinsons Disease
2. Research Published in Science Translational Medicine Underscores Value of Depression Gene Therapy License Held by Neurologix
3. Neurologix Reports Third Quarter 2010 Financial Results
4. Neurologix Completes Additional $7 Million Financing
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... DEERFIELD, Ill. , Aug. 21, 2014 /PRNewswire/ ... reports Baxter International Inc. today announced positive results ... BAX 855, an investigational, extended half-life recombinant factor ... ADVATE [Antihemophilic Factor (Recombinant)], which met its primary ... the prophylaxis arm compared to the on-demand arm. ...
(Date:8/21/2014)... Canadian Epilepsy Alliance (CEA) is thrilled to announce the launch ... the most common neurological disorder in Canada ... tells a fictional story based on the experiences of 14-year-old ... "Despite the fact that epilepsy affects 1 ... lack of awareness out there," says Gail Dempsey , ...
(Date:8/21/2014)... -- Seventy-one percent of Americans believe the abuse of strong prescription ... and safety issue in the United States ... Repass & Partners, a Cincinnati based ... of the prescription medication abuse problem and the need for ... situation facing our country," Rex Repass , CEO of ...
Breaking Medicine Technology:Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5Action Heroes Harness Powers to Educate Children About Epilepsy 2Action Heroes Harness Powers to Educate Children About Epilepsy 3Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3
... (Nasdaq: CADX ) today announced that it has ... common stock at a price to the public of $3.75 ... shares, after deducting the underwriting discounts and commissions and estimated ... has granted the underwriters for the offering a 30-day option ...
... 15, 2011 Reportlinker.com announces that a ... its catalogue: The Outlook ... http://www.reportlinker.com/p0617406/The-Outlook-for-Pharmaceuticals-in-North-East-Asia ... pharmaceutical markets that present immense potential for ...
Cached Medicine Technology:Cadence Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2Cadence Pharmaceuticals Announces Pricing of Public Offering of Common Stock 3The Outlook for Pharmaceuticals in North East Asia 2The Outlook for Pharmaceuticals in North East Asia 3The Outlook for Pharmaceuticals in North East Asia 4
(Date:8/22/2014)... With the stage set for the National Association ... which will be held in Boston August 23-26 - ... online opinion section, Podium. The op-ed “ To ... Steven C. Anderson, IOM, CAE, president & CEO of ... University School of Pharmacy – Worcester/Manchester. , Offered ...
(Date:8/22/2014)... 2014 Millennium Treatment Group has recently noticed ... high level of drug use among teenagers. The treatment facility ... addiction and work to minimize drug abuse. , America is ... drug addiction in history. According to the National Institute ... Americans aged 12 or older—or 9.2 percent of the population—had ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 The regional ... Toyota Indiana is on the grow again. ... jobs by summer 2016 to boost production of the ... bring Toyota Indiana’s overall investment to $4 billion. This ... America while providing additional flexibility to adjust its product ...
(Date:8/22/2014)... (PHILADELPHIA) - A Penn Medicine team has found ... significantly reduce urinary tract infections in hospital patients ... of the alert was simplified, the rate of ... decide whether their patients need urinary catheters in ... reassess the need for catheters that have not ...
(Date:8/22/2014)... 22, 2014 (HealthDay News) -- Many Americans know little about ... possibility of an outbreak in the United States, a new ... are worried that there will be a major Ebola outbreak ... or an immediate family member will get sick with the ... Harvard School of Public Health poll. However, those opinions ...
Breaking Medicine News(10 mins):Health News:The Boston Globe Publishes Value of Pharmacy Op-ed as NACDS Total Store Expo Begins 2Health News:The Boston Globe Publishes Value of Pharmacy Op-ed as NACDS Total Store Expo Begins 3Health News:Millennium Treatment Group Sees Increase in Marijuana Use Among Youth 2Health News:Toyota Indiana Adding 300 Jobs to Build More Highlanders 2Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 2Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 3Health News:Many Americans Harbor Unfounded Fears About Ebola Outbreak: Survey 2
... Today at the 6th International AIDS Society ... the Drugs for Neglected Diseases initiative (DNDi) announced ... to address critical unmet treatment needs of children ... young children has largely been eliminated in high-income ...
... of Chemistry and NYU Langone Medical Center have developed ... in many types of cancer. The compound is described ... Chemical Biology. The researchers examined signaling ... a major underlying cause of various developmental disorders and ...
... , SATURDAY, July 16 (HealthDay News) -- As you ... in mind. The sun on your skin may feel nice, ... one major sunburn when they were a child or teen have ... kind of skin cancer, later in life, according to the Skin ...
... research conducted at Harvard Medical School and the Harvard ... informing the controversial debate currently surrounding national health care ... edition of the American Journal of Preventive Medicine, ... Aakanksha Pande, a doctoral student in the Department of ...
... taking certain antidepressant medications are at an increased risk of ... prescription or a dose increase of their current drug, according ... of Hebrew SeniorLife, an affiliate of Harvard Medical School., Published ... the study found that nursing home residents have a fivefold ...
... , FRIDAY, July 15 (HealthDay News) -- The ... reactions to small amounts of alcohol, a new study finds. ... 20s after they drank a small amount of red wine ... the wine, participants, left ventricular function decreased, according to the ...
Cached Medicine News:Health News:DNDi launches new drug development program to address treatment needs of children with HIV/AIDS 2Health News:DNDi launches new drug development program to address treatment needs of children with HIV/AIDS 3Health News:Massachusetts health-care reform increased access to care, particularly among disadvantaged 2Health News:Nursing home residents at heightened risk of falling in the days following 2Health News:Alcohol Affects Left, Right Heart Chambers Differently 2
... utilize Linvatecs exclusive Shockflex prism system to ... Using the latest technology, our 3CCD Camera ... and brightness. The Camera Heads are available ... configured with a number of optical couplers ...
... an integrated coupler can be steam sterilized using ... it is cool to the touch and ready ... Smarthead technology allowing each head to store procedure ... head has been used is displayed on the ...
... invasive surgery is founded on superior medical ... of 3-Chip cameras, 1-Chip cameras, Light sources, ... your demanding needs., ,Superior resolution and ... our 3-Chip cameras, and are the benchmark ...
... high-resolution 1-Chip Camera System provides easy-to-use features, ... small scope. The camera head construction is ... ,Complete 1-Chip Camera System for Microscopic Application, ... Camera Control Unit (CCU) with power cord ...
Medicine Products: